As of June 06, 2026, Lexaria Bioscience's top three insider holders are Christopher Bunka (Director, 373.54K shares), Christopher Bunka (Chief Executive Officer, 281.91K shares), Christopher Bunka (Director, 273.54K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Christopher Bunka | - | 373,543 | 0 | 10 Jan, 2025 |
| Albert L Jr Reese | - | 10,917 | 0 | 25 May, 2022 |
| Richard Christopher | Chief Executive Officer | 65,000 | 0 | 30 Jul, 2025 |
| John Martin Docherty | President Cso | 5,376 | 0 | 30 Jul, 2025 |
| William Edward Mckechnie | - | 18,191 | 0 | 30 Jul, 2025 |
| Catherine C. Turkel | - | 3,100 | 0 | 13 Aug, 2024 |
| Vanessa Carle | Secretary | 750 | 0 | 30 Jul, 2025 |
| Gregory Downey | Chief Financial Officer | 1,954 | 0 | 18 Oct, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Mar, 2026 | Christopher Bunka | common shares | D | 100,000 | $0.00 | 273,543 | D | G |
| 29 Jul, 2025 | Vanessa Carle | common shares | A | 750 | $0.91 | 750 | D | P |
| 29 Jul, 2025 | William Edward Mckechnie | common shares | A | 5,000 | $0.91 | 18,191 | D | P |
| 29 Jul, 2025 | William Edward Mckechnie | common shares | A | 5,000 | $0.91 | 18,191 | D | P |
| 29 Jul, 2025 | Richard Christopher | common shares | A | 15,000 | $0.91 | 65,000 | D | P |
| 29 Jul, 2025 | John Martin Docherty | common shares | A | 5,376 | $0.93 | 5,376 | D | P |
| 29 Jul, 2025 | Christopher Bunka | common shares | A | 15,600 | $0.92 | 270,012 | I | P |
| 30 Jul, 2025 | Christopher Bunka | common shares | A | 11,900 | $0.91 | 281,912 | I | P |
| 15 May, 2025 | Baljinder Bhullar | Stock Options | A | 11,000 | $0.00 | 11,000 | D | A |
| 15 May, 2025 | Michael Elliot Shankman | Stock Options | A | 50,000 | $0.00 | 100,000 | D | A |
| 15 May, 2025 | Michael Elliot Shankman | Stock Options | A | 50,000 | $0.00 | 100,000 | D | A |
| 15 May, 2025 | Richard Christopher | Stock Options | A | 150,000 | $0.00 | 350,000 | D | A |
| 15 May, 2025 | Vanessa Carle | Stock Options | A | 15,000 | $0.00 | 75,000 | D | A |
| 15 May, 2025 | John Martin Docherty | Stock Options | A | 150,000 | $0.00 | 310,834 | D | A |
| 15 May, 2025 | Albert L Jr Reese | Stock Options | A | 11,000 | $0.00 | 43,000 | D | A |
| 15 May, 2025 | Albert L Jr Reese | Stock Options | A | 11,000 | $0.00 | 43,000 | D | A |
| 15 May, 2025 | Christopher Bunka | Stock Options | A | 11,000 | $0.00 | 184,834 | D | A |
| 15 May, 2025 | William Edward Mckechnie | Stock Options | A | 11,000 | $0.00 | 63,000 | D | A |
| 15 May, 2025 | Nicholas W Baxter | Stock Options | A | 11,000 | $0.00 | 63,000 | D | A |
| 15 May, 2025 | William Edward Mckechnie | Stock Options | A | 11,000 | $0.00 | 63,000 | D | A |